Steven Kafka, Daniel O'Day, and more 

Foundation Medicine announced four executive promotions and the hiring of a global marketing senior vice president. Additionally, it proposed changes to its board in connection to its strategic collaboration with Roche. 

Those who were promoted include Steven Kafka, Jason Ryan, Elaine Labrecque, and Sarah Larson. Kafka has been promoted to president. He currently is Foundation Medicine's COO and will maintain that position. He joined the company in 2013 and was previously COO and CFO at Aileron Therapeutics. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.